Discovery of circulating RNA biomarkers in autism
|Dr Ken Pangfirstname.lastname@example.org|
Autism is a complex, heterogeneous neurodevelopmental disability with an early childhood onset and a lifelong course. The identification of biomarkers to define biologically homogeneous subgroups, predict risk, and aid the diagnosis of autism would greatly facilitate the management of this common disorder, which affects ~1% of the population.
This research project seeks to identify circulating RNA biomarkers that are dysregulated in autism and, using this information, aims to develop a diagnostic blood test for autism. In this way, the research seeks to overcome the current difficulties that exist around obtaining a diagnosis of autism and, by doing so, should help to facilitate intervention and thus improve outcomes for autistic children and their families.
- Dr Ken Pang, Consultant Paediatrician
- Dr Nicole van Bergen, Research Officer
- Dr Rocio Ruis, PhD Candidate
- Ms Simran Kaur, PhD Candidate
- Ms Marilou Barrios, PhD Candidate
- Mr Blake Smith, PhD Candidate
- Ms Lucy Liu, MA Candidate
- Metabolic Research Group – Kids Research Institute, Sydney Children’s Hospitals Network
- Professor Carolyn Sue – Kolling Research Institute, Sydney
- Professor David Ravine – School of Pathology and Laboratory Medicine, University of Perth
- Professor Helen Leonard – Telethon Kids Institute, Perth
- Dr Yiran Guo and Dr Brendan Keating – Center for Advanced Genomics, Children’s Hospital of Philadelphia
- Dr Carole Lister, Luxembourg Centre for Systems Biomedicine, Universite du Luxembourg
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.